echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Shandong Lu anti-dagli net film listing application to be accepted by CDE

    Shandong Lu anti-dagli net film listing application to be accepted by CDE

    • Last Update: 2020-06-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    news, recently, CDE accepted the Shandong Lu anti-dagli net film listing application, for China's first imitationproducts(http://DaglenetDapagliflozin was developed by Persimmon Squibb and then sold global sales to AstraZenecawas first approved by the European EMA on November 12, 2012, making it the first SGLT2 inhibitor to be approved for the treatment of type 2 diabetesIn March 2019, Dagrenet was approved as an insulin-assisted oral supplement in Europe and Japan
    the drug(http://for the treatment of adult patients with type 1 diabetes (T1D), however, just last week, the u.Sfda(http://formally rejected Dagre's application for the conditionIn addition, according to relevant data, the global market in the net market of The Dageli market continued to expand, the near-year growth rate continued to maintain more than 30%, 2018 sales of $2.85 billion
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.